Recognition of Leishmania parasites by innate immunity

Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry

Volumn 9, Issue 2, 2009, Pages 106-127

  Silvestre, Ricardo ^a,b   Santarém, Nuno ^a,b   Tavares, Joana ^a,b   Silva, Ana Marta ^a,b   Cordeiro da Silva, Anabela ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

Antigen presenting cells; Host parasite interaction; Innate immunity; Leishmania; TLR2; Toll like receptors

Indexed keywords

C REACTIVE PROTEIN; CD40 LIGAND; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C3BI; COMPLEMENT COMPONENT C5A RECEPTOR; FAS ANTIGEN; FAS LIGAND; GAMMA INTERFERON; GLYCOPROTEIN; GLYCOPROTEIN GP63; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P40; JANUS KINASE; LIPOPHOSPHOGLYCAN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYELOID DIFFERENTIATION FACTOR 88; NITRIC OXIDE; PROSTAGLANDIN E2; PROTEIN KINASE C; STAT PROTEIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; AMASTIGOTE; ANTIGEN PRESENTATION; APOPTOSIS; CELL FUNCTION; CYTOKINE RELEASE; DENDRITIC CELL; HOST PARASITE INTERACTION; INNATE IMMUNITY; LEISHMANIA; LEISHMANIASIS; MACROPHAGE; NEUTROPHIL; NONHUMAN; PHAGOCYTE; PROMASTIGOTE; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

EID: 70350001577     PISSN: 18715222     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152209789000713     Document Type: Review

References (191)

1. Kimblin, N.; Peters, N.; Debrabant, A.; Secundino, N.; Egen, J.; Lawyer, P.; Fay, M.P.; Kamhawi, S.; Sacks, D. Quantification of the infectious dose of Leishmania major transmitted to the skin by single sand flies. Proc. Natl. Acad. Sci. USA, 2008, 105, 10125-10130.
2. Sacks, D.; Kamhawi, S. Molecular aspects of parasite-vector and vector-host interactions in leishmaniasis. Annu. Rev. Microbiol., 2001, 55, 453-483.
3. Murray, H.W.; Stern, J.J.; Welte, K.; Rubin, B.Y.; Carriero, S.M.; Nathan, C.F. Experimental visceral leishmaniasis: production of interleukin 2 and interferon-gamma, tissue immune reaction, and response to treatment with interleukin 2 and interferon-gamma. J. Immunol., 1987, 138, 2290-2297.
4. Scott, P.; Natovitz, P.; Coffman, R.L.; Pearce, E.; Sher, A. Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. J. Exp. Med., 1988, 168, 1675-1684.
5. Pintado, V.; Lopez-Velez, R. HIV-associated visceral leishmaniasis. Clin. Microbiol. Infect., 2001, 7, 291-300.
6. Darrah, P.A.; Patel, D.T.; De Luca, P.M.; Lindsay, R.W.; Davey, D.F.; Flynn, B.J.; Hoff, S.T.; Andersen, P.; Reed, S.G.; Morris, S.L.; Roederer, M.; Seder, R.A. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat. Med., 2007, 13, 843-850.
7. Kaye, P.M.; Curry, A.J.; Blackwell, J.M. Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis. J. Immunol., 1991, 146, 2763-2770.
8. Kemp, M.; Kurtzhals, J.A.; Bendtzen, K.; Poulsen, L.K.; Hansen, M.B.; Koech, D.K.; Kharazmi, A.; Theander, T.G. Leishmania donovani-reactive Th1- and Th2-like T-cell clones from individuals who have recovered from visceral leishmaniasis. Infect. Immun., 1993, 61, 1069-1073.
9. Alexander, J.; Bryson, K. T helper (h)1/Th2 and Leishmania: paradox rather than paradigm. Immunol. Lett., 2005, 99, 17-23.
10. Silvestre, R.; Cordeiro-Da-Silva, A.; Santarem, N.; Vergnes, B.; Sereno, D.; Ouaissi, A. SIR2-deficient Leishmania infantum induces a defined IFN-gamma/IL-10 pattern that correlates with protection. J. Immunol., 2007, 179, 3161-3170.
11. Oliveira, F.; Jochim, R.C.; Valenzuela, J.G.; Kamhawi, S. Sand flies, Leishmania, and transcriptome-borne solutions. Parasitol. Int., 2008, 58, 1-5.
12. Ouaissi, A.; Ouaissi, M. Molecular basis of Trypanosoma cruzi and Leishmania interaction with their host(s): exploitation of immune and defense mechanisms by the parasite leading to persistence and chronicity, features reminiscent of immune system evasion strategies in cancer diseases. Arch. Immunol. Ther. Exp. (Warsz), 2005, 53, 102-114.
13. Joshi, P.B.; Kelly, B.L.; Kamhawi, S.; Sacks, D.L.; McMaster, W.R. Targeted gene deletion in Leishmania major identifies leishmanolysin (GP63) as a virulence factor. Mol. Biochem. Parasitol., 2002, 120, 33-40.
14. Puentes, S.M.; Da Silva, R.P.; Sacks, D.L.; Hammer, C.H.; Joiner, K.A. Serum resistance of metacyclic stage Leishmania major promastigotes is due to release of C5b-9. J. Immunol., 1990, 145, 4311-4316.
15. McConville, M.J.; Turco, S.J.; Ferguson, M.A.; Sacks, D.L. Developmental modification of lipophosphoglycan during the differentiation of Leishmania major promastigotes to an infectious stage. EMBO J., 1992, 11, 3593-3600.
16. Kane, M.M.; Mosser, D.M. Leishmania parasites and their ploys to disrupt macrophage activation. Curr. Opin. Hematol., 2000, 7, 26-31.
17. Sacks, D.; Sher, A. Evasion of innate immunity by parasitic protozoa. Nat. Immunol., 2002, 3, 1041-1047.
18. Brittingham, A.; Morrison, C.J.; McMaster, W.R.; McGwire, B.S.; Chang, K.P.; Mosser, D.M. Role of the Leishmania surface protease gp63 in complement fixation, cell adhesion, and resistance to complement-mediated lysis. J. Immunol., 1995, 155, 3102-3111.
19. Rizvi, F.S.; Ouaissi, M.A.; Marty, B.; Santoro, F.; Capron, A. The major surface protein of Leishmania promastigotes is a fibronectin-like molecule. Eur. J. Immunol., 1988, 18, 473-476.
20. Blackwell, J.M.; Ezekowitz, R.A.; Roberts, M.B.; Channon, J.Y.; Sim, R.B.; Gordon, S. Macrophage complement and lectin-like receptors bind Leishmania in the absence of serum. J. Exp. Med., 1985, 162, 324-331.
21. Wilson, M.E.; Pearson, R.D. Evidence that Leishmania donovani utilizes a mannose receptor on human mononuclear phagocytes to establish intracellular parasitism. J. Immunol., 1986, 136, 4681-4688.
22. Culley, F.J.; Harris, R.A.; Kaye, P.M.; McAdam, K.P.; Raynes, J.G. C-reactive protein binds to a novel ligand on Leishmania donovani and increases uptake into human macrophages. J. Immunol., 1996, 156, 4691-4696.
23. Talamas-Rohana, P.; Wright, S.D.; Lennartz, M.R.; Russell, D.G. Lipophosphoglycan from Leishmania mexicana promastigotes binds to members of the CR3, p150,95 and LFA-1 family of leukocyte integrins. J. Immunol., 1990, 144, 4817-4824.
24. Hawlisch, H.; Belkaid, Y.; Baelder, R.; Hildeman, D.; Gerard, C.; Kohl, J. C5a negatively regulates toll-like receptor 4-induced immune responses. Immunity, 2005, 22, 415-426.
25. Guy, R.A.; Belosevic, M. Comparison of receptors required for entry of Leishmania major amastigotes into macrophages. Infect. Immun., 1993, 61, 1553-1558.
26. van Zandbergen, G.; Klinger, M.; Mueller, A.; Dannenberg, S.; Gebert, A.; Solbach, W.; Laskay, T. Cutting edge: neutrophil granulocyte serves as a vector for Leishmania entry into macrophages. J. Immunol., 2004, 173, 6521-6525.
27. Laufs, H.; Muller, K.; Fleischer, J.; Reiling, N.; Jahnke, N.; Jensenius, J.C.; Solbach, W.; Laskay, T. Intracellular survival of Leishmania major in neutrophil granulocytes after uptake in the absence of heat-labile serum factors. Infect. Immun., 2002, 70, 826-835.
28. van Zandbergen, G.; Bollinger, A.; Wenzel, A.; Kamhawi, S.; Voll, R.; Klinger, M.; Muller, A.; Holscher, C.; Herrmann, M.; Sacks, D.; Solbach, W.; Laskay, T. Leishmania disease development depends on the presence of apoptotic promastigotes in the virulent inoculum. Proc. Natl. Acad. Sci. USA, 2006, 103, 13837-13842.
29. Peters, N.C.; Egen, J.G.; Secundino, N.; Debrabant, A.; Kimblin, N.; Kamhawi, S.; Lawyer, P.; Fay, M.P.; Germain, R.N.; Sacks, D. In vivo imaging reveals an essential role for neutrophils in leishmaniasis transmitted by sand flies. Science, 2008, 321, 970-974.
30. Rittig, M.G.; Bogdan, C. Leishmania-host-cell interaction: complexities and alternative views. Parasitol. Today, 2000, 16, 292-297.
31. Desjardins, M.; Descoteaux, A. Inhibition of phagolysosomal biogenesis by the Leishmania lipophosphoglycan. J. Exp. Med., 1997, 185, 2061-2068.
32. Spath, G.F.; Garraway, L.A.; Turco, S.J.; Beverley, S.M. The role(s) of lipophosphoglycan (LPG) in the establishment of Leishmania major infections in mammalian hosts. Proc. Natl. Acad. Sci. USA, 2003, 100, 9536-9541.
33. Duclos, S.; Desjardins, M. Subversion of a young phagosome: the survival strategies of intracellular pathogens. Cell Microbiol., 2000, 2, 365-377.
34. Woelbing, F.; Kostka, S.L.; Moelle, K.; Belkaid, Y.; Sunderkoetter, C.; Verbeek, S.; Waisman, A.; Nigg, A.P.; Knop, J.; Udey, M.C.; von Stebut, E. Uptake of Leishmania major by dendritic cells is mediated by Fcgamma receptors and facilitates acquisition of protective immunity. J. Exp. Med., 2006, 203, 177-188.
35. Antoine, J.C.; Prina, E.; Courret, N.; Lang, T. Leishmania spp.: on the interactions they establish with antigenpresenting cells of their mammalian hosts. Adv. Parasitol., 2004, 58, 1-68.
36. Colmenares, M.; Corbi, A.L.; Turco, S.J.; Rivas, L. The dendritic cell receptor DC-SIGN discriminates among species and life cycle forms of Leishmania. J. Immunol., 2004, 172, 1186-1190.
37. van Kooyk, Y.; Geijtenbeek, T.B. DC-SIGN: escape mechanism for pathogens. Nat. Rev. Immunol., 2003, 3, 697-709.
38. Bogdan, C.; Donhauser, N.; Doring, R.; Rollinghoff, M.; Diefenbach, A.; Rittig, M.G. Fibroblasts as host cells in latent leishmaniosis. J. Exp. Med., 2000, 191, 2121-2130.
39. Spath, G.F.; Lye, L.F.; Segawa, H.; Turco, S.J.; Beverley, S.M. Identification of a compensatory mutant (lpg2-REV) of Leishmania major able to survive as amastigotes within macrophages without LPG2-dependent glycoconjugates and its significance to virulence and immunization strategies. Infect. Immun., 2004, 72, 3622-3627.
40. Bogdan, C.; Rollinghoff, M. The immune response to Leishmania: mechanisms of parasite control and evasion. Int. J. Parasitol., 1998, 28, 121-134.
41. Wanderley, J.L.; Benjamin, A.; Real, F.; Bonomo, A.; Moreira, M.E.; Barcinski, M.A. Apoptotic mimicry: an altruistic behavior in host/ Leishmania interplay. Braz. J. Med. Biol. Res., 2005, 38, 807-812.
42. de Freitas Balanco, J.M.; Moreira, M.E.; Bonomo, A.; Bozza, P.T.; Amarante-Mendes, G.; Pirmez, C.; Barcinski, M.A. Apoptotic mimicry by an obligate intracellular parasite downregulates macrophage microbicidal activity. Curr. Biol., 2001, 11, 1870-1873.
43. Wei, X.Q.; Charles, I.G.; Smith, A.; Ure, J.; Feng, G.J.; Huang, F.P.; Xu, D.; Muller, W.; Moncada, S.; Liew, F.Y. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature, 1995, 375, 408-411.
44. Murray, H.W.; Nathan, C.F. Macrophage microbicidal mechanisms in vivo: reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani. J. Exp. Med., 1999, 189, 741-746.
45. Blos, M.; Schleicher, U.; Soares Rocha, F.J.; Meissner, U.; Rollinghoff, M.; Bogdan, C. Organ-specific and stage-dependent control of Leishmania major infection by inducible nitric oxide synthase and phagocyte NADPH oxidase. Eur. J. Immunol., 2003, 33, 1224-1234.
46. Buchmuller-Rouiller, Y.; Mauel, J. Correlation between enhanced oxidative metabolism and leishmanicidal activity in activated macrophages from healer and nonhealer mouse strains. J. Immunol., 1986, 136, 3884-3890.
47. Descoteaux, A.; Turco, S.J. Glycoconjugates in Leishmania infectivity. Biochim. Biophys. Acta, 1999, 1455, 341-352.
48. Chan, J.; Fujiwara, T.; Brennan, P.; McNeil, M.; Turco, S.J.; Sibille, J.C.; Snapper, M.; Aisen, P.; Bloom, B.R. Microbial glycolipids: possible virulence factors that scavenge oxygen radicals. Proc. Natl. Acad. Sci. USA, 1989, 86, 2453-2457.
49. Proudfoot, L.; Nikolaev, A.V.; Feng, G.J.; Wei, W.Q.; Ferguson, M.A.; Brimacombe, J.S.; Liew, F.Y. Regulation of the expression of nitric oxide synthase and leishmanicidal activity by glycoconjugates of Leishmania lipophosphoglycan in murine macrophages. Proc. Natl. Acad. Sci. USA, 1996, 93, 10984-10989.
50. Ghosh, S.; Goswami, S.; Adhya, S. Role of superoxide dismutase in survival of Leishmania within the macrophage. Biochem. J., 2003, 369, 447-452.
51. Barr, S.D.; Gedamu, L. Role of peroxidoxins in Leishmania chagasi survival. Evidence of an enzymatic defense against nitrosative stress. J. Biol. Chem., 2003, 278, 10816-10823.
52. Castro, H.; Sousa, C.; Santos, M.; Cordeiro-da-Silva, A.; Flohe, L.; Tomas, A.M. Complementary antioxidant defense by cytoplasmic and mitochondrial peroxiredoxins in Leishmania infantum. Free Radic. Biol. Med., 2002, 33, 1552-1562.
53. Seay, M.B.; Heard, P.L.; Chaudhuri, G. Surface Zn-proteinase as a molecule for defense of Leishmania mexicana amazonensis promastigotes against cytolysis inside macrophage phagolysosomes. Infect. Immun., 1996, 64, 5129-5137.
54. Schneider, P.; Rosat, J.P.; Bouvier, J.; Louis, J.; Bordier, C. Leishmania major: differential regulation of the surface metalloprotease in amastigote and promastigote stages. Exp. Parasitol., 1992, 75, 196-206.
55. Pimenta, P.F.; Saraiva, E.M.; Sacks, D.L. The comparative fine structure and surface glycoconjugate expression of three life stages of Leishmania major. Exp. Parasitol., 1991, 72, 191-204.
56. Scott, P.; Artis, D.; Uzonna, J.; Zaph, C. The development of effector and memory T cells in cutaneous leishmaniasis: the implications for vaccine development. Immunol. Rev., 2004, 201, 318-338.
57. Kima, P.E. The amastigote forms of Leishmania are experts at exploiting host cell processes to establish infection and persist. Int. J. Parasitol., 2007, 37, 1087-1096.
58. Carrera, L.; Gazzinelli, R.T.; Badolato, R.; Hieny, S.; Muller, W.; Kuhn, R.; Sacks, D.L. Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice. J. Exp. Med., 1996, 183, 515-526.
59. Weinheber, N.; Wolfram, M.; Harbecke, D.; Aebischer, T. Phagocytosis of Leishmania mexicana amastigotes by macrophages leads to a sustained suppression of IL-12 production. Eur. J. Immunol., 1998, 28, 2467-2477.
60. Belkaid, Y.; Butcher, B.; Sacks, D.L. Analysis of cytokine production by inflammatory mouse macrophages at the single-cell level: selective impairment of IL-12 induction in Leishmania-infected cells. Eur. J. Immunol., 1998, 28, 1389-1400.
61. Sutterwala, F.S.; Noel, G.J.; Clynes, R.; Mosser, D.M. Selective suppression of interleukin-12 induction after macrophage receptor ligation. J. Exp. Med., 1997, 185, 1977-1985.
62. Marth, T.; Kelsall, B.L. Regulation of interleukin-12 by complement receptor 3 signaling. J. Exp. Med., 1997, 185, 1987-1995.
63. Charmoy, M.; Megnekou, R.; Allenbach, C.; Zweifel, C.; Perez, C.; Monnat, K.; Breton, M.; Ronet, C.; Launois, P.; Tacchini-Cottier, F. Leishmania major induces distinct neutrophil phenotypes in mice that are resistant or susceptible to infection. J. Leukoc. Biol., 2007, 82, 288-299.
64. von Stebut, E.; Belkaid, Y.; Jakob, T.; Sacks, D.L.; Udey, M.C. Uptake of Leishmania major amastigotes results in activation and interleukin 12 release from murine skin-derived dendritic cells: implications for the initiation of anti-Leishmania immunity. J. Exp. Med., 1998, 188, 1547-1552.
65. Flohe, S.B.; Bauer, C.; Flohe, S.; Moll, H. Antigen-pulsed epidermal Langerhans cells protect susceptible mice from infection with the intracellular parasite Leishmania major. Eur. J. Immunol., 1998, 28, 3800-3811.
66. Liese, J.; Schleicher, U.; Bogdan, C. The innate immune response against Leishmania parasites. Immunobiology, 2008, 213, 377-387.
67. Schleicher, U.; Liese, J.; Knippertz, I.; Kurzmann, C.; Hesse, A.; Heit, A.; Fischer, J.A.; Weiss, S.; Kalinke, U.; Kunz, S.; Bogdan, C. NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs. J. Exp. Med., 2007, 204, 893-906.
68. Bennett, C.L.; Misslitz, A.; Colledge, L.; Aebischer, T.; Blackburn, C.C. Silent infection of bone marrow-derived dendritic cells by Leishmania mexicana amastigotes. Eur. J. Immunol., 2001, 31, 876-883.
69. McDowell, M.A.; Marovich, M.; Lira, R.; Braun, M.; Sacks, D. Leishmania priming of human dendritic cells for CD40 ligand-induced interleukin-12p70 secretion is strain and species dependent. Infect. Immun., 2002, 70, 3994-4001.
70. Soong, L. Modulation of dendritic cell function by Leishmania parasites. J. Immunol., 2008, 180, 4355-4360.
71. Meagher, L.C.; Savill, J.S.; Baker, A.; Fuller, R.W.; Haslett, C. Phagocytosis of apoptotic neutrophils does not induce macrophage release of thromboxane B2. J. Leukoc. Biol., 1992, 52, 269-273.
72. Stern, M.; Savill, J.; Haslett, C. Human monocyte-derived macrophage phagocytosis of senescent eosinophils undergoing apoptosis. Mediation by alpha v beta 3/CD36/thrombospondin recognition mechanism and lack of phlogistic response. Am. J. Pathol., 1996, 149, 911-921.
73. Stuart, L.M.; Lucas, M.; Simpson, C.; Lamb, J.; Savill, J.; Lacy-Hulbert, A. Inhibitory effects of apoptotic cell ingestion upon endotoxin-driven myeloid dendritic cell maturation. J. Immunol., 2002, 168, 1627-1635.
74. Kim, S.; Elkon, K.B.; Ma, X. Transcriptional suppression of interleukin-12 gene expression following phagocytosis of apoptotic cells. Immunity, 2004, 21, 643-653.
75. Voll, R.E.; Herrmann, M.; Roth, E.A.; Stach, C.; Kalden, J. R.; Girkontaite, I. Immunosuppressive effects of apoptotic cells. Nature, 1997, 390, 350-351.
76. Tosello-Trampont, A.C.; Nakada-Tsukui, K.; Ravichandran, K.S. Engulfment of apoptotic cells is negatively regulated by Rho-mediated signaling. J. Biol. Chem., 2003, 278, 49911-49919.
77. Erwig, L.P.; Gordon, S.; Walsh, G.M.; Rees, A.J. Previous uptake of apoptotic neutrophils or ligation of integrin receptors downmodulates the ability of macrophages to ingest apoptotic neutrophils. Blood, 1999, 93, 1406-1412.
78. Muller, K.; van Zandbergen, G.; Hansen, B.; Laufs, H.; Jahnke, N.; Solbach, W.; Laskay, T. Chemokines, natural killer cells and granulocytes in the early course of Leishmania major infection in mice. Med. Microbiol. Immunol., 2001, 190, 73-76.
79. Laskay, T.; van Zandbergen, G.; Solbach, W. Neutrophil granulocytes as host cells and transport vehicles for intracellular pathogens: apoptosis as infection-promoting factor. Immunobiology, 2008, 213, 183-191.
80. Sutterwala, F.S.; Noel, G.J.; Salgame, P.; Mosser, D.M. Reversal of proinflammatory responses by ligating the macrophage Fcgamma receptor type I. J. Exp. Med., 1998, 188, 217-222.
81. Li, J.; Hunter, C.A.; Farrell, J.P. Anti-TGF-beta treatment promotes rapid healing of Leishmania major infection in mice by enhancing in vivo nitric oxide production. J. Immunol., 1999, 162, 974-979.
82. Noben-Trauth, N.; Lira, R.; Nagase, H.; Paul, W.E.; Sacks, D.L. The relative contribution of IL-4 receptor signaling and IL-10 to susceptibility to Leishmania major. J. Immunol., 2003, 170, 5152-5158.
83. Anderson, C.F.; Lira, R.; Kamhawi, S.; Belkaid, Y.; Wynn, T.A.; Sacks, D. IL-10 and TGF-beta control the establishment of persistent and transmissible infections produced by Leishmania tropica in C57BL/6 mice. J. Immunol., 2008, 180, 4090-4097.
84. Wilson, M.E.; Young, B.M.; Davidson, B.L.; Mente, K.A.; McGowan, S.E. The importance of TGF-beta in murine visceral leishmaniasis. J. Immunol., 1998, 161, 6148-6155.
85. Belkaid, Y.; Piccirillo, C.A.; Mendez, S.; Shevach, E.M.; Sacks, D.L. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature, 2002, 420, 502-507.
86. Lira, R.; Doherty, M.; Modi, G.; Sacks, D. Evolution of lesion formation, parasitic load, immune response, and reservoir potential in C57BL/6 mice following high- and low-dose challenge with Leishmania major. Infect. Immun., 2000, 68, 5176-5182.
87. Anderson, C.F.; Oukka, M.; Kuchroo, V.J.; Sacks, D. CD4 (+)CD25(-)Foxp3(-) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. J. Exp. Med., 2007, 204, 285-297.
88. Nylen, S.; Maurya, R.; Eidsmo, L.; Manandhar, K.D.; Sundar, S.; Sacks, D. Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis. J. Exp. Med., 2007, 204, 805-817.
89. Uzonna, J.E.; Joyce, K.L.; Scott, P. Low dose Leishmania major promotes a transient T helper cell type 2 response that is down-regulated by interferon gamma-producing CD8+ T cells. J. Exp. Med., 2004, 199, 1559-1566.
90. Locksley, R.M.; Reiner, S.L.; Hatam, F.; Littman, D.R.; Killeen, N. Helper T cells without CD4: control of leishmaniasis in CD4-deficient mice. Science, 1993, 261, 1448-1451.
91. Reiner, N.E.; Ng, W.; McMaster, W.R. Parasite-accessory cell interactions in murine leishmaniasis. II. Leishmania donovani suppresses macrophage expression of class I and class II major histocompatibility complex gene products. J. Immunol., 1987, 138, 1926-1932.
92. Courret, N.; Prina, E.; Mougneau, E.; Saraiva, E.M.; Sacks, D.L.; Glaichenhaus, N.; Antoine, J.C. Presentation of the Leishmania antigen LACK by infected macrophages is dependent upon the virulence of the phagocytosed parasites. Eur. J. Immunol., 1999, 29, 762-773.
93. Campbell, K.A.; Ovendale, P.J.; Kennedy, M.K.; Fanslow, W.C.; Reed, S.G.; Maliszewski, C.R. CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity, 1996, 4, 283-289.
94. Soong, L.; Xu, J.C.; Grewal, I.S.; Kima, P.; Sun, J.; Longley, B.J., Jr.; Ruddle, N.H.; McMahon-Pratt, D.; Flavell, R.A. Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. Immunity, 1996, 4, 263-273.
95. Ferlin, W.G.; von der Weid, T.; Cottrez, F.; Ferrick, D.A.; Coffman, R.L.; Howard, M.C. The induction of a protective response in Leishmania major-infected BALB/c mice with anti-CD40 mAb. Eur. J. Immunol., 1998, 28, 525-531.
96. Murray, H.W.; Lu, C.M.; Brooks, E.B.; Fichtl, R.E.; DeVecchio, J.L.; Heinzel, F.P. Modulation of T-cell costimulation as immunotherapy or immunochemotherapy in experimental visceral leishmaniasis. Infect. Immun., 2003, 71, 6453-6462.
97. Chamekh, M. CD40-CD40L interaction in immunity against protozoan infections. J. Biomed. Biotechnol., 2007, 2007, 59430.
98. Saha, B.; Das, G.; Vohra, H.; Ganguly, N.K.; Mishra, G.C. Macrophage-T cell interaction in experimental visceral leishmaniasis: failure to express costimulatory molecules on Leishmania-infected macrophages and its implication in the suppression of cell-mediated immunity. Eur. J. Immunol., 1995, 25, 2492-2498.
99. Pinelli, E.; Gonzalo, R.M.; Boog, C.J.; Rutten, V.P.; Gebhard, D.; del Real, G.; Ruitenberg, E.J. Leishmania infantum-specific T cell lines derived from asymptomatic dogs that lyse infected macrophages in a major histocompatibility complex-restricted manner. Eur. J. Immunol., 1995, 25, 1594-1600.
100. Favali, C.; Tavares, N.; Clarencio, J.; Barral, A.; Barral-Netto, M.; Brodskyn, C. Leishmania amazonensis infection impairs differentiation and function of human dendritic cells. J. Leukoc. Biol., 2007, 82, 1401-1406.
101. Xin, L.; Li, K.; Soong, L. Down-regulation of dendritic cell signaling pathways by Leishmania amazonensis amasti-gotes. Mol. Immunol., 2008, 45, 3371-3382.
102. Ato, M.; Stager, S.; Engwerda, C.R.; Kaye, P.M. Defective CCR7 expression on dendritic cells contributes to the development of visceral leishmaniasis. Nat. Immunol., 2002, 3, 1185-1191.
103. Engwerda, C.R.; Ato, M.; Kaye, P.M. Macrophages, pathology and parasite persistence in experimental visceral leishmaniasis. Trends Parasitol., 2004, 20, 524-530.
104. Gazzinelli, R.T.; Denkers, E.Y. Protozoan encounters with Toll-like receptor signalling pathways: implications for host parasitism. Nat. Rev. Immunol., 2006, 6, 895-906.
105. Potestio, M.; D'Agostino, P.; Romano, G.C.; Milano, S.; Ferlazzo, V.; Aquino, A.; Di Bella, G.; Caruso, R.; Gambino, G.; Vitale, G.; Mansueto, S.; Cillari, E. CD4+ CCR5+ and CD4+ CCR3+ lymphocyte subset and monocyte apoptosis in patients with acute visceral leishmaniasis. Immunology, 2004, 113, 260-268.
106. Alexander, C.E.; Kaye, P.M.; Engwerda, C.R. CD95 is required for the early control of parasite burden in the liver of Leishmania donovani-infected mice. Eur. J. Immunol., 2001, 31, 1199-1210.
107. Mukherjee, P.; Sen, P.C.; Ghose, A.C. Lymph node cells from BALB/c mice with chronic visceral leishmaniasis exhibiting cellular anergy and apoptosis: involvement of Ser/Thr phosphatase. Apoptosis, 2006, 11, 2013-2029.
108. Eidsmo, L.; Wolday, D.; Berhe, N.; Sabri, F.; Satti, I.; El Hassan, A.M.; Sundar, S.; Chiodi, F.; Akuffo, H. Alteration of Fas and Fas ligand expression during human visceral leishmaniasis. Clin. Exp. Immunol., 2002, 130, 307-313.
109. Chakour, R.; Guler, R.; Bugnon, M.; Allenbach, C.; Garcia, I.; Mauel, J.; Louis, J.; Tacchini-Cottier, F. Both the Fas ligand and inducible nitric oxide synthase are needed for control of parasite replication within lesions in mice infected with Leishmania major whereas the contribution of tumor necrosis factor is minimal. Infect. Immun., 2003, 71, 5287-5295.
110. Kanaly, S.T.; Nashleanas, M.; Hondowicz, B.; Scott, P. TNF receptor p55 is required for elimination of inflammatory cells following control of intracellular pathogens. J. Immunol., 1999, 163, 3883-3889.
111. Allenbach, C.; Launois, P.; Mueller, C.; Tacchini-Cottier, F. An essential role for transmembrane TNF in the resolution of the inflammatory lesion induced by Leishmania major infection. Eur. J. Immunol., 2008, 38, 720-731.
112. Reckling, S.; Divanovic, S.; Karp, C.L.; Wojciechowski, S.; Belkaid, Y.; Hildeman, D. Proapoptotic Bcl-2 family member Bim promotes persistent infection and limits protective immunity. Infect. Immun., 2008, 76, 1179-1185.
113. Moore, K.J.; Matlashewski, G. Intracellular infection by Leishmania donovani inhibits macrophage apoptosis. J. Immunol., 1994, 152, 2930-2937.
114. Aga, E.; Katschinski, D.M.; van Zandbergen, G.; Laufs, H.; Hansen, B.; Muller, K.; Solbach, W.; Laskay, T. Inhibition of the spontaneous apoptosis of neutrophil granulocytes by the intracellular parasite Leishmania major. J. Immunol., 2002, 169, 898-905.
115. Akarid, K.; Arnoult, D.; Micic-Polianski, J.; Sif, J.; Estaquier, J.; Ameisen, J.C. Leishmania major-mediated prevention of programmed cell death induction in infected macrophages is associated with the repression of mitochondrial release of cytochrome c. J. Leukoc. Biol., 2004, 76, 95-103.
116. Lisi, S.; Sisto, M.; Acquafredda, A.; Spinelli, R.; Schiavone, M.; Mitolo, V.; Brandonisio, O.; Panaro, M. Infection with Leishmania infantum Inhibits actinomycin D-induced apoptosis of human monocytic cell line U-937. J. Eukaryot. Microbiol., 2005, 52, 211-217.
117. Ruhland, A.; Leal, N.; Kima, P.E. Leishmania promastigotes activate PI3K/Akt signalling to confer host cell resistance to apoptosis. Cell Microbiol., 2007, 9, 84-96.
118. Eilam, Y.; El-On, J.; Spira, D.T. Leishmania major: excreted factor, calcium ions, and the survival of amastigotes. Exp. Parasitol., 1985, 59, 161-168.
119. Olivier, M.; Baimbridge, K.G.; Reiner, N.E. Stimulusresponse coupling in monocytes infected with Leishmania. Attenuation of calcium transients is related to defective agonist-induced accumulation of inositol phosphates. J. Immunol., 1992, 148, 1188-1196.
120. McNeely, T.B.; Turco, S.J. Inhibition of protein kinase C activity by the Leishmania donovani lipophosphoglycan. Biochem. Biophys. Res. Commun., 1987, 148, 653-657.
121. Blanchette, J.; Racette, N.; Faure, R.; Siminovitch, K.A.; Olivier, M. Leishmania-induced increases in activation of macrophage SHP-1 tyrosine phosphatase are associated with impaired IFN-gamma-triggered JAK2 activation. Eur. J. Immunol., 1999, 29, 3737-3744.
122. Matte, C.; Marquis, J.F.; Blanchette, J.; Gros, P.; Faure, R.; Posner, B.I.; Olivier, M. Peroxovanadium-mediated protection against murine leishmaniasis: role of the modulation of nitric oxide. Eur. J. Immunol., 2000, 30, 2555-2564.
123. Forget, G.; Siminovitch, K.A.; Brochu, S.; Rivest, S.; Radzioch, D.; Olivier, M. Role of host phosphotyrosine phosphatase SHP-1 in the development of murine leishmaniasis. Eur. J. Immunol., 2001, 31, 3185-3196.
124. Spath, G.F.; McDowell, M.A.; Beverley, S.M. Leishmania major intracellular survival is not altered in SHP-1 deficient mev or CD45-/- mice. Exp. Parasitol., 2008, 120, 275-279.
125. Yang, Z.; Mosser, D.M.; Zhang, X. Activation of the MAPK, ERK, following Leishmania amazonensis infection of macrophages. J. Immunol., 2007, 178, 1077-1085.
126. Halle, M.; Gomez, M.A.; Stuible, M.; Shimizu, H.; McMaster, W.R.; Olivier, M.; Tremblay, M.L. The Leishmania surface protease GP63 cleaves multiple intracellular proteins and actively participates in p38 mitogen activated protein kinase inactivation. J. Biol. Chem., 2009, 284(11), 6893-6908.
127. Prive, C.; Descoteaux, A. Leishmania donovani promastigotes evade the activation of mitogen-activated protein kinases p38, c-Jun N-terminal kinase, and extracellular signal-regulated kinase-1/2 during infection of naive macrophages. Eur. J. Immunol., 2000, 30, 2235-2244.
128. Ruhland, A.; Kima, P.E. Activation of PI3K/Akt signaling has a dominant negative effect on IL-12 production by macrophages infected with Leishmania amazonensis promastigotes. Exp. Parasitol., 2009, 122(1), 28-36.
129. Ohtani, M.; Nagai, S.; Kondo, S.; Mizuno, S.; Nakamura, K.; Tanabe, M.; Takeuchi, T.; Matsuda, S.; Koyasu, S. Mammalian target of rapamycin and glycogen synthase kinase 3 differentially regulate lipopolysaccharide-induced interleukin-12 production in dendritic cells. Blood 2008, 112, 635-643.
130. Galm, O.; Yoshikawa, H.; Esteller, M.; Osieka, R.; Herman, J. G. SOCS-1, a negative regulator of cytokine signaling, is frequently silenced by methylation in multiple myeloma. Blood, 2003, 101, 2784-2788.
131. Bertholet, S.; Dickensheets, H.L.; Sheikh, F.; Gam, A.A.; Donnelly, R.P.; Kenney, R.T. Leishmania donovani-induced expression of suppressor of cytokine signaling 3 in human macrophages: a novel mechanism for intracellular parasite suppression of activation. Infect. Immun., 2003, 71, 2095-2101.
132. Kinjyo, I.; Inoue, H.; Hamano, S.; Fukuyama, S.; Yoshimura, T.; Koga, K.; Takaki, H.; Himeno, K.; Takaesu, G.; Kobayashi, T.; Yoshimura, A. Loss of SOCS3 in T helper cells resulted in reduced immune responses and hyperproduction of interleukin 10 and transforming growth factor-beta 1. J. Exp. Med., 2006, 203, 1021-1031.
133. Brender, C.; Columbus, R.; Metcalf, D.; Handman, E.; Starr, R.; Huntington, N.; Tarlinton, D.; Odum, N.; Nicholson, S.E.; Nicola, N.A.; Hilton, D.J.; Alexander, W.S. SOCS5 is expressed in primary B and T lymphoid cells but is dispensable for lymphocyte production and function. Mol. Cell Biol., 2004, 24, 6094-6103.
134. Akira, S.; Uematsu, S.; Takeuchi, O. Pathogen recognition and innate immunity. Cell, 2006, 124, 783-801.
135. Janeway, C.A., Jr.; Medzhitov, R. Innate immune recognition. Annu. Rev. Immunol., 2002, 20, 197-216.
136. Medzhitov, R.; Janeway, C.A., Jr. Innate immunity: impact on the adaptive immune response. Curr. Opin. Immunol., 1997, 9, 4-9.
137. Muzio, M.; Mantovani, A. Toll-like receptors. Microbes Infect., 2000, 2, 251-255.
138. Kawai, T.; Akira, S. TLR signaling. Semin. Immunol., 2007, 19, 24-32.
139. Carpenter, S.; O'Neill, L.A. How important are Toll-like receptors for antimicrobial responses? Cell Microbiol., 2007, 9, 1891-1901.
140. Aliprantis, A.O.; Yang, R.B.; Mark, M.R.; Suggett, S.; Devaux, B.; Radolf, J.D.; Klimpel, G.R.; Godowski, P.; Zychlinsky, A. Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science, 1999, 285, 736-739.
141. Schwandner, R.; Dziarski, R.; Wesche, H.; Rothe, M.; Kirschning, C.J. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J. Biol. Chem., 1999, 274, 17406-17409.
142. Jeannin, P.; Renno, T.; Goetsch, L.; Miconnet, I.; Aubry, J.P.; Delneste, Y.; Herbault, N.; Baussant, T.; Magistrelli, G.; Soulas, C.; Romero, P.; Cerottini, J.C.; Bonnefoy, J.Y. OmpA targets dendritic cells, induces their maturation and delivers antigen into the MHC class I presentation pathway. Nat. Immunol., 2000, 1, 502-509.
143. Ouaissi, A.; Guilvard, E.; Delneste, Y.; Caron, G.; Magistrelli, G.; Herbault, N.; Thieblemont, N.; Jeannin, P. The Trypanosoma cruzi Tc52-released protein induces human dendritic cell maturation, signals via Toll-like receptor 2, and confers protection against lethal infection. J. Immunol., 2002, 168, 6366-6374.
144. Massari, P.; Henneke, P.; Ho, Y.; Latz, E.; Golenbock, D.T.; Wetzler, L.M. Cutting edge: Immune stimulation by neisserial porins is toll-like receptor 2 and MyD88 dependent. J. Immunol., 2002, 168, 1533-1537.
145. Ozinsky, A.; Underhill, D.M.; Fontenot, J.D.; Hajjar, A.M.; Smith, K.D.; Wilson, C.B.; Schroeder, L.; Aderem, A. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc. Natl. Acad. Sci. USA, 2000, 97, 13766-13771.
146. Iwaki, D.; Nishitani, C.; Mitsuzawa, H.; Hyakushima, N.; Sano, H.; Kuroki, Y. The CD14 region spanning amino acids 57-64 is critical for interaction with the extracellular Toll-like receptor 2 domain. Biochem. Biophys. Res. Commun., 2005, 328, 173-176.
147. Hoebe, K.; Georgel, P.; Rutschmann, S.; Du, X.; Mudd, S.; Crozat, K.; Sovath, S.; Shamel, L.; Hartung, T.; Zahringer, U.; Beutler, B. CD36 is a sensor of diacylglycerides. Nature, 2005, 433, 523-527.
148. Akira, S.; Takeda, K. Toll-like receptor signalling. Nat. Rev. Immunol., 2004, 4, 499-511.
149. Hawn, T.R.; Ozinsky, A.; Underhill, D.M.; Buckner, F.S.; Akira, S.; Aderem, A. Leishmania major activates IL-1 alpha expression in macrophages through a MyD88-dependent pathway. Microbes Infect., 2002, 4, 763-771.
150. de Veer, M.J.; Curtis, J.M.; Baldwin, T.M.; DiDonato, J. A.; Sexton, A.; McConville, M.J.; Handman, E.; Schofield, L. MyD88 is essential for clearance of Leishmania major: possible role for lipophosphoglycan and Toll-like receptor 2 signaling. Eur. J. Immunol., 2003, 33, 2822-2831.
151. Muraille, E.; De Trez, C.; Brait, M.; De Baetselier, P.; Leo, O.; Carlier, Y. Genetically resistant mice lacking MyD88-adapter protein display a high susceptibility to Leishmania major infection associated with a polarized Th2 response. J. Immunol., 2003, 170, 4237-4241.
152. Kropf, P.; Freudenberg, M.A.; Modolell, M.; Price, H.P.; Herath, S.; Antoniazi, S.; Galanos, C.; Smith, D.F.; Muller, I. Toll-like receptor 4 contributes to efficient control of infection with the protozoan parasite Leishmania major. Infect. Immun., 2004, 72, 1920-1928.
153. Antoniazi, S.; Price, H.P.; Kropf, P.; Freudenberg, M.A.; Galanos, C.; Smith, D.F.; Muller, I. Chemokine gene expression in toll-like receptor-competent and -deficient mice infected with Leishmania major. Infect. Immun., 2004, 72, 5168-5174.
154. Ribeiro-Gomes, F.L.; Moniz-de-Souza, M.C.; Alexandre-Moreira, M.S.; Dias, W.B.; Lopes, M.F.; Nunes, M.P.; Lungarella, G.; DosReis, G.A. Neutrophils activate macrophages for intracellular killing of Leishmania major through recruitment of TLR4 by neutrophil elastase. J. Immunol., 2007, 179, 3988-3994.
155. Flandin, J.F.; Chano, F.; Descoteaux, A. RNA interference reveals a role for TLR2 and TLR3 in the recognition of Leishmania donovani promastigotes by interferon-gamma-primed macrophages. Eur. J. Immunol., 2006, 36, 411-420.
156. Becker, I.; Salaiza, N.; Aguirre, M.; Delgado, J.; Carrillo-Carrasco, N.; Kobeh, L.G.; Ruiz, A.; Cervantes, R.; Torres, A.P.; Cabrera, N.; Gonzalez, A.; Maldonado, C.; Isibasi, A. Leishmania lipophosphoglycan (LPG) activates NK cells through toll-like receptor-2. Mol. Biochem. Parasitol., 2003, 130, 65-74.
157. Qazi, K.R.; Oehlmann, W.; Singh, M.; Lopez, M.C.; Fernandez, C. Microbial heat shock protein 70 stimulatory properties have different TLR requirements. Vaccine, 2007, 25, 1096-1103.
158. Whitaker, S.M.; Colmenares, M.; Pestana, K.G.; McMahon-Pratt, D. Leishmania pifanoi proteoglycolipid complex P8 induces macrophage cytokine production through Toll-like receptor 4. Infect. Immun., 2008, 76, 2149-2156.
159. Underhill, D.M. Toll-like receptors and microbes take aim at each other. Curr. Opin. Immunol., 2004, 16, 483-487.
160. Chandra, D.; Naik, S. Leishmania donovani infection down-regulates TLR2-stimulated IL-12p40 and activates IL-10 in cells of macrophage/ monocytic lineage by modulating MAPK pathways through a contact-dependent mechanism. Clin. Exp. Immunol., 2008, 154(2), 224-234.
161. Zhang, W.W.; Matlashewski, G. Immunization with a Toll-like receptor 7 and/or 8 agonist vaccine adjuvant increases protective immunity against Leishmania major in BALB/c mice. Infect. Immun., 2008, 76, 3777-3783.
162. Parody, N.; Soto, M.; Requena, J.M.; Alonso, C. Adjuvant guided polarization of the immune humoral response against a protective multicomponent antigenic protein (Q) from Leishmania infantum. A CpG + Q mix protects Balb/c mice from infection. Parasite Immunol., 2004, 26, 283-293.
163. Lange, U.G.; Mastroeni, P.; Blackwell, J.M.; Stober, C.B. DNA- Salmonella enterica serovar Typhimurium primer-booster vaccination biases towards T helper 1 responses and enhances protection against Leishmania major infection in mice. Infect. Immun., 2004, 72, 4924-4928.
164. Chen, M.; Aosai, F.; Norose, K.; Mun, H.S.; Takeuchi, O.; Akira, S.; Yano, A. Involvement of MyD88 in host defense and the down-regulation of anti-heat shock protein 70 autoantibody formation by MyD88 in Toxoplasma gondii-infected mice. J. Parasitol., 2002, 88, 1017-1019.
165. Scanga, C.A.; Aliberti, J.; Jankovic, D.; Tilloy, F.; Bennouna, S.; Denkers, E.Y.; Medzhitov, R.; Sher, A. Cutting edge: MyD88 is required for resistance to Toxoplasma gondii infection and regulates parasite-induced IL-12 production by dendritic cells. J. Immunol., 2002, 168, 5997-6001.
166. Campos, M.A.; Closel, M.; Valente, E.P.; Cardoso, J.E.; Akira, S.; Alvarez-Leite, J.I.; Ropert, C.; Gazzinelli, R.T. Impaired production of proinflammatory cytokines and host resistance to acute infection with Trypanosoma cruzi in mice lacking functional myeloid differentiation factor 88. J. Immunol., 2004, 172, 1711-1718.
167. Fremond, C.M.; Yeremeev, V.; Nicolle, D.M.; Jacobs, M.; Quesniaux, V. F.; Ryffel, B. Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88. J. Clin. Invest., 2004, 114, 1790-1799.
168. Drennan, M.B.; Stijlemans, B.; Van den Abbeele, J.; Quesniaux, V.J.; Barkhuizen, M.; Brombacher, F.; De Baetselier, P.; Ryffel, B.; Magez, S. The induction of a type 1 immune response following a Trypanosoma brucei infection is MyD88 dependent. J. Immunol., 2005, 175, 2501-2509.
169. Takeuchi, O.; Hoshino, K.; Akira, S. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J. Immunol., 2000, 165, 5392-5396.
170. Echchannaoui, H.; Frei, K.; Schnell, C.; Leib, S.L.; Zimmerli, W.; Landmann, R. Toll-like receptor 2-deficient mice are highly susceptible to Streptococcus pneumoniae meningitis because of reduced bacterial clearing and enhanced inflammation. J. Infect. Dis., 2002, 186, 798-806.
171. Koedel, U.; Angele, B.; Rupprecht, T.; Wagner, H.; Roggenkamp, A.; Pfister, H.W.; Kirschning, C.J. Toll-like receptor 2 participates in mediation of immune response in experimental pneumococcal meningitis. J. Immunol., 2003, 170, 438-444.
172. Mun, H.S.; Aosai, F.; Norose, K.; Chen, M.; Piao, L.X.; Takeuchi, O.; Akira, S.; Ishikura, H.; Yano, A. TLR2 as an essential molecule for protective immunity against Toxoplasma gondii infection. Int. Immunol., 2003, 15, 1081-1087.
173. Heldwein, K.A.; Liang, M.D.; Andresen, T.K.; Thomas, K. E.; Marty, A.M.; Cuesta, N.; Vogel, S.N.; Fenton, M.J. TLR2 and TLR4 serve distinct roles in the host immune response against Mycobacterium bovis BCG. J. Leukoc. Biol., 2003, 74, 277-286.
174. Gomes, M.S.; Florido, M.; Cordeiro, J.V.; Teixeira, C.M.; Takeuchi, O.; Akira, S.; Appelberg, R. Limited role of the Toll-like receptor-2 in resistance to Mycobacterium avium. Immunology, 2004, 111, 179-185.
175. Gomes, M.S.; Sousa Fernandes, S.; Cordeiro, J.V.; Silva Gomes, S.; Vieira, A.; Appelberg, R. Engagement of Toll-like receptor 2 in mouse macrophages infected with Mycobacterium avium induces non-oxidative and TNF-independent anti-mycobacterial activity. Eur. J. Immunol., 2008, 38, 2180-2189.
176. Sugawara, I.; Yamada, H.; Li, C.; Mizuno, S.; Takeuchi, O.; Akira, S. Mycobacterial infection in TLR2 and TLR6 knockout mice. Microbiol. Immunol., 2003, 47, 327-336.
177. Reiling, N.; Holscher, C.; Fehrenbach, A.; Kroger, S.; Kirschning, C.J.; Goyert, S.; Ehlers, S. Cutting edge: Toll-like receptor (TLR)2- and TLR4-mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis. J. Immunol., 2002, 169, 3480-3484.
178. Sing, A.; Rost, D.; Tvardovskaia, N.; Roggenkamp, A.; Wiedemann, A.; Kirschning, C.J.; Aepfelbacher, M.; Heesemann, J. Yersinia V-antigen exploits toll-like receptor 2 and CD14 for interleukin 10-mediated immunosuppression. J. Exp. Med., 2002, 196, 1017-1024.
179. Netea, M.G.; Warris, A.; Van der Meer, J.W.; Fenton, M. J.; Verver-Janssen, T.J.; Jacobs, L.E.; Andresen, T.; Verweij, P.E.; Kullberg, B.J. Aspergillus fumigatus evades immune recognition during germination through loss of toll-like receptor-4-mediated signal transduction. J. Infect. Dis., 2003, 188, 320-326.
180. Bellocchio, S.; Montagnoli, C.; Bozza, S.; Gaziano, R.; Rossi, G.; Mambula, S.S.; Vecchi, A.; Mantovani, A.; Levitz, S.M.; Romani, L. The contribution of the Toll-like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo. J. Immunol., 2004, 172, 3059-3069.
181. Sing, A.; Reithmeier-Rost, D.; Granfors, K.; Hill, J.; Roggenkamp, A.; Heesemann, J. A hypervariable N-terminal region of Yersinia LcrV determines Toll-like receptor 2-mediated IL-10 induction and mouse virulence. Proc. Natl. Acad. Sci. USA, 2005, 102, 16049-16054.
182. Re, F.; Strominger, J.L. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells. J. Biol. Chem., 2001, 276, 37692-37699.
183. Takeuchi, O.; Hoshino, K.; Kawai, T.; Sanjo, H.; Takada, H.; Ogawa, T.; Takeda, K.; Akira, S. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity, 1999, 11, 443-451.
184. Sutmuller, R.P.; den Brok, M.H.; Kramer, M.; Bennink, E.J.; Toonen, L.W.; Kullberg, B.J.; Joosten, L.A.; Akira, S.; Netea, M.G.; Adema, G.J. Toll-like receptor 2 controls expansion and function of regulatory T cells. J. Clin. Invest., 2006, 116, 485-494.
185. Kamhawi, S.; Modi, G.B.; Pimenta, P.F.; Rowton, E.; Sacks, D.L. The vectorial competence of Phlebotomus sergenti is specific for Leishmania tropica and is controlled by species-specific, lipophosphoglycan-mediated midgut attachment. Parasitology, 2000, 121(Pt 1), 25-33.
186. Celada, A.; Gray, P.W.; Rinderknecht, E.; Schreiber, R.D. Evidence for a gamma-interferon receptor that regulates macrophage tumoricidal activity. J. Exp. Med., 1984, 160, 55-74.
187. Swanson, M.S.; Isberg, R.R. Association of Legionella pneumophila with the macrophage endoplasmic reticulum. Infect. Immun., 1995, 63, 3609-3620.
188. Inaba, K.; Inaba, M.; Romani, N.; Aya, H.; Deguchi, M.; Ikehara, S.; Muramatsu, S.; Steinman, R.M. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/ macrophage colony-stimulating factor. J. Exp. Med., 1992, 176, 1693-1702.
189. Sereno, D.; Roy, G.; Lemesre, J.L.; Papadopoulou, B.; Ouellette, M. DNA transformation of Leishmania infantum axenic amastigotes and their use in drug screening. Antimicrob. Agents Chemother., 2001, 45, 1168-1173.
190. Roy, G.; Dumas, C.; Sereno, D.; Wu, Y.; Singh, A.K.; Tremblay, M.J.; Ouellette, M.; Olivier, M.; Papadopoulou, B. Episomal and stable expression of the luciferase reporter gene for quantifying Leishmania spp. infections in macrophages and in animal models. Mol. Biochem. Parasitol., 2000, 110, 195-206.
191. Buffet, P.A.; Sulahian, A.; Garin, Y.J.; Nassar, N.; Derouin, F. Culture microtitration: a sensitive method for quantifying Leishmania infantum in tissues of infected mice. Antimicrob. Agents Chemother., 1995, 39, 2167-2168.